I have been looking at several boards and there is definitely some serious concern about the press conference in the companies that deal in and support recreation marijuana. I read several posts talking about sticking with CBD and medical stocks. We may experience a little volume boost, especially if we can get some decent news. If I was James I would stress the legality of the product in the next pr, whatever it pertains to.
News 
Market Data 
Discover 
AI
